CRISPR, Gene Therapies, and Cure Pricing Conundrums
Motley Fool Money
00:00
The CRISPR Revolution: Innovation and Ethics
This chapter explores CRISPR-Cas9 technology, comparing it to molecular scissors for genetic editing and tracing its origins as a bacterial defense mechanism. It discusses both the transformative potential of CRISPR in treating genetic diseases and the significant ethical concerns surrounding its use, particularly in germline editing. The chapter highlights ongoing advancements in therapies, while addressing the challenges and risks associated with precise genetic modifications.
Play episode from 01:30
Transcript
